Patents by Inventor Frank Molock

Frank Molock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic devices comprising photochromic materials with reactive substituents
    Patent number: 11874434
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: January 16, 2024
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS
    Publication number: 20220137262
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Application
    Filed: January 18, 2022
    Publication date: May 5, 2022
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • Ophthalmic devices comprising photochromic materials with reactive substituents
    Patent number: 11256002
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: February 22, 2022
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • Ophthalmic compositions comprising polyether substituted polymers
    Patent number: 10441533
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: October 15, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS
    Publication number: 20190129067
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Application
    Filed: December 19, 2018
    Publication date: May 2, 2019
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • Ophthalmic devices comprising photochromic materials with reactive sub substituents
    Patent number: 10197707
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: February 5, 2019
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS
    Publication number: 20180064642
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Application
    Filed: November 14, 2017
    Publication date: March 8, 2018
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • METHODS FOR STABILIZING OXIDATIVELY UNSTABLE COMPOSITIONS
    Publication number: 20180050026
    Abstract: Ophthalmic compositions and methods of preparing such compositions are disclosed.
    Type: Application
    Filed: October 26, 2017
    Publication date: February 22, 2018
    Inventors: Shivkumar Mahadevan, Frank Molock, Vandeeta Khanolkar
  • Ophthalmic compositions comprising polyether substituted polymers
    Patent number: 9849081
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: December 26, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS
    Publication number: 20170157037
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Application
    Filed: February 16, 2017
    Publication date: June 8, 2017
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • Ophthalmic compositions comprising polyether substituted polymers
    Patent number: 9606263
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: March 28, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS
    Publication number: 20170042933
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • METHODS FOR STABILIZING OXIDATIVELY UNSTABLE COMPOSITIONS
    Publication number: 20170007592
    Abstract: Ophthalmic compositions and methods of preparing such compositions are disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: January 12, 2017
    Inventors: Shivkumar Mahadevan, Frank Molock, Vandeeta Khanolkar
  • Ophthalmic compositions comprising polyether substituted polymers
    Patent number: 9511089
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: December 6, 2016
    Inventors: Frank Molock, Katherine Osborn Lorenz, Shivkumar Mahadevan
  • Methods for stabilizing oxidatively unstable compositions
    Patent number: 9474746
    Abstract: Ophthalmic compositions and methods of preparing such compositions are disclosed.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: October 25, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Frank Molock, Vandeeta Khanolkar
  • OPHTHALMIC COMPOSITIONS COMPRISING POLYETHER SUBSTITUTED POLYMERS
    Publication number: 20160158272
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and comprising linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Application
    Filed: February 16, 2016
    Publication date: June 9, 2016
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • Ophthalmic compositions comprising polyether substituted polymers
    Patent number: 9297928
    Abstract: The present invention relates to ophthalmic solutions and devices comprising at least one water soluble polymer having a molecular weight of at least about 500,000 Daltons and linear or branched polyether pendant groups having a molecular weight of at least about 300.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: March 29, 2016
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Frank Molock, Kathrine Osborn Lorenz, Shivkumar Mahadevan
  • OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS
    Publication number: 20150241601
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 27, 2015
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • Ophthalmic devices comprising photochromic materials with reactive substituents
    Patent number: 9052438
    Abstract: Various non-limiting embodiments of the present disclosure relate to ophthalmic devices comprising photochromic materials comprising a reactive substituent. For example, the present disclosure contemplates ophthalmic devices comprising photochromic materials, such as photochromic naphthopyrans and indeno-fused naphthopyrans having a reactive substituent comprising a reactive moiety linked to the photochromic naphthopyran by one or more linking groups. In certain non-limiting embodiments, the reactive moiety comprises a polymerizable moiety. In other non-limiting embodiments, the reactive moiety comprises a nucleophilic moiety. Other non-limiting embodiments of the present disclosure relate to methods of making the photochromic ophthalmic device, wherein the photochromic ophthalmic devices comprise the photochromic naphthopyrans described herein.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 9, 2015
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Wenjing Xiao, Barry Van Gemert, Shivkumar Mahadevan, Frank Molock
  • METHODS FOR STABILIZING OXIDATIVELY UNSTABLE COMPOSITIONS
    Publication number: 20140011843
    Abstract: Ophthalmic compositions and methods of preparing such compositions are disclosed.
    Type: Application
    Filed: May 15, 2013
    Publication date: January 9, 2014
    Applicant: Johnson & Johnson Vision Care, Inc.
    Inventors: Shivkumar Mahadevan, Frank Molock, Vandeeta Khanolkar